SENATOR Pia Cayetano was guest of honor and speaker in the recent partnership between the Philippine-based Ambica Biotechnologies and Reliance Life Sciences of India in providing high-end molecular diagnostics and genetic testing in the country held at the Intercon Hotel in Makati City.

Both companies are accredited with the National Accreditation Board for Laboratory Testing (NABL) and College of American Pathologists (CAP). Reliance Life Sciences is highly regarded as one of Southeast Asia’s finest in the field of molecular diagnostics and genetics.

Through the alliance, Ambica Biotechnologies will provide accurate and affordable access to molecular diagnostics and genetic testing for more Filipinos.

Cayetano signified her support towards the advancement of preventive healthcare medicine and modern diagnostics in the Philippines. She urged the medical professionals to support modern diagnostic testing and allow this kind of program to grow in the country.

“There is a need to review policies on the availability and affordability of medicines and promote healthy lifestyle and health care services,” she stresses. The lady Senator has been a constant supporter of preventive healthcare and healthy lifestyle through her “Pinay in Action” program.

“We have to allow the development of modern technology in preventing diseases. The death of my son Gabriel and my father of liver cancer has been my inspiration towards this kind of advocacy,” she said.

Her son was diagnosed in 2001 of pneumonia as a complication from a genetic disease called Trisomy. Dr. Philip Cruz, Ambica Biotechnologies Executive president, said that technologies make it possible to detect genetic diseases in an offspring even before implantation. Genetic testing of an unborn infant can provide information that can help families prepare for the pregnancy, child care and counseling.